share_log

Marijuana Reclassification And DEA: Congressional Report Outlines Rescheduling Limits

Marijuana Reclassification And DEA: Congressional Report Outlines Rescheduling Limits

大麻重新分類和緝毒局:國會報告概述了改期限制
Benzinga ·  01/17 07:55
The U.S. Drug Enforcement Administration (DEA) might finally budge on it is decades-long cannabis criminalization, but don't hold your breath for legal weed shops just yet. In a new report published Tuesday, the Congressional Research Service (CRS) explained the limitations of rescheduling, stressing state-legal markets would still be in federal crosshairs, facing potential raids and prosecution.
美國緝毒局(DEA)可能最終會讓步,因爲這是長達數十年的大麻定罪,但暫時不要爲合法的大麻商店屏住呼吸。在週二發佈的一份新報告中,國會研究局(CRS)解釋了改期的侷限性,強調州合法市場仍將受到聯邦政府的嚴格審查,面臨潛在的突襲和起訴。
While rescheduling cannabis from Schedule I (no accepted medical use and high potential for abuse) to Schedule III (accepted medical use and low potential for abuse) sounds promising, it would not necessarily legalize the booming state-legal cannabis industry.
儘管將大麻從附表一(不被接受的醫療用途和濫用的可能性很大)改爲附表三(可接受的醫療用途和低濫用的可能性)聽起來很有希望,但這不一定會使蓬勃發展的國家合法大麻產業合法化。
"Moving...
C...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論